STEPHEN VAN DEVENTER
Listed on 1 Form D filing across 1+ issuer
· Executive Officer
Associated issuers
- BioGene Therapeutics Inc. CIK 2140719 · TX
Filings (1)
-
BioGene Therapeutics Inc.D · Jul 23, 2026 · TX · Biotechnology$4.5MView filing →